Danny Sullivan
@mrdannysullivan.bsky.social
Writer of science, technology, and longevity stuff.
Reposted by Danny Sullivan
‘Healthspan must not remain a privilege of the wealthy; it should become a universal right’
Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit.
#healthspan #aging #longevity #GlobalHealthspanSummit
Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit.
#healthspan #aging #longevity #GlobalHealthspanSummit
‘Healthspan must not remain a privilege of the wealthy; it should become a universal right’
Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit.
longevity.technology
January 31, 2025 at 7:55 PM
‘Healthspan must not remain a privilege of the wealthy; it should become a universal right’
Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit.
#healthspan #aging #longevity #GlobalHealthspanSummit
Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit.
#healthspan #aging #longevity #GlobalHealthspanSummit
Reposted by Danny Sullivan
Investing in the global race to develop healthspan therapeutics
a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan.
#healthspan #investment #biotech #AI
a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan.
#healthspan #investment #biotech #AI
Investing in the global race to develop healthspan therapeutics
a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan.
longevity.technology
February 3, 2025 at 5:49 PM
Investing in the global race to develop healthspan therapeutics
a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan.
#healthspan #investment #biotech #AI
a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan.
#healthspan #investment #biotech #AI
Reposted by Danny Sullivan
Fauna Bio’s first development candidate targets heart failure
Drug emerges from research into cardiac protection mechanisms of hibernating ground squirrels – clinical trial expected in 2026.
#longevity #biotech #heartfailure
Drug emerges from research into cardiac protection mechanisms of hibernating ground squirrels – clinical trial expected in 2026.
#longevity #biotech #heartfailure
Fauna Bio's first development candidate targets heart failure
Drug emerged from research into the cardiac protection mechanisms of hibernating ground squirrels; clinical trial expected in 2026.
longevity.technology
February 3, 2025 at 6:06 PM
Fauna Bio’s first development candidate targets heart failure
Drug emerges from research into cardiac protection mechanisms of hibernating ground squirrels – clinical trial expected in 2026.
#longevity #biotech #heartfailure
Drug emerges from research into cardiac protection mechanisms of hibernating ground squirrels – clinical trial expected in 2026.
#longevity #biotech #heartfailure
Reposted by Danny Sullivan
Oura and Dexcom to combine glucose sensing and wearable health tracking
Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn.
#longevity #wearables #CGM #glucose #metabolism #investment
Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn.
#longevity #wearables #CGM #glucose #metabolism #investment
Oura and Dexcom to combine glucose sensing and wearable health tracking
Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn.
longevity.technology
November 21, 2024 at 3:42 PM
Oura and Dexcom to combine glucose sensing and wearable health tracking
Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn.
#longevity #wearables #CGM #glucose #metabolism #investment
Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn.
#longevity #wearables #CGM #glucose #metabolism #investment
Reposted by Danny Sullivan
Longevity biotech aims to unleash the power of NAD+ against age-related diseases
MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration.
#longevity #biotech #NAD+
MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration.
#longevity #biotech #NAD+
Longevity biotech aims to unleash the power of NAD+ against age-related diseases
MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration.
longevity.technology
November 21, 2024 at 3:44 PM
Longevity biotech aims to unleash the power of NAD+ against age-related diseases
MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration.
#longevity #biotech #NAD+
MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration.
#longevity #biotech #NAD+